These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11921319)

  • 1. A general model of the impact of absenteeism on employers and employees.
    Pauly MV; Nicholson S; Xu J; Polsky D; Danzon PM; Murray JF; Berger ML
    Health Econ; 2002 Apr; 11(3):221-31. PubMed ID: 11921319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take some days off, why don't you? Endogenous sick leave and pay.
    Skåtun JD
    J Health Econ; 2003 May; 22(3):379-402. PubMed ID: 12683958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of bipolar disorder in an employed population from an employer perspective.
    Gardner HH; Kleinman NL; Brook RA; Rajagopalan K; Brizee TJ; Smeeding JE
    J Clin Psychiatry; 2006 Aug; 67(8):1209-18. PubMed ID: 16965198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sick Leave Due to Stress, What are the Costs for Dutch Employers?
    Wolvetang S; van Dongen JM; Speklé E; Coenen P; Schaafsma F
    J Occup Rehabil; 2022 Dec; 32(4):764-772. PubMed ID: 35575823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.
    Kleinman NL; Brook RA; Doan JF; Melkonian AK; Baran RW
    J Clin Psychiatry; 2009 Aug; 70(8):1098-104. PubMed ID: 19758521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Productivity costs before and after absence from work: as important as common?
    Brouwer WB; van Exel NJ; Koopmanschap MA; Rutten FF
    Health Policy; 2002 Aug; 61(2):173-87. PubMed ID: 12088890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of obesity in the workplace.
    Schmier JK; Jones ML; Halpern MT
    Scand J Work Environ Health; 2006 Feb; 32(1):5-11. PubMed ID: 16539166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Work-site health promotion: an economic model.
    Patton JP
    J Occup Med; 1991 Aug; 33(8):868-73. PubMed ID: 1941281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating quantitative and qualitative approaches to assess wintertime illness-related absenteeism and its direct and indirect costs among the private sector in Ulaanbaatar.
    Ganbat M; Erdenebileg N; Batbold C; Nergui S; Anderson R; Wigfall C; Amarsanaa N; Heikens A; Sarantuya M; Warburton D
    PLoS One; 2022; 17(2):e0263220. PubMed ID: 35113912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ill health and distraction at work: Costs and drivers for productivity loss.
    Bialowolski P; McNeely E; VanderWeele TJ; Weziak-Bialowolska D
    PLoS One; 2020; 15(3):e0230562. PubMed ID: 32231382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.
    Krol M; Brouwer WB; Severens JL; Kaper J; Evers SM
    Soc Sci Med; 2012 Dec; 75(11):1981-8. PubMed ID: 22925428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and absence of HCV-infected employees by disease stage.
    Baran RW; Samp JC; Walker DR; Smeeding JE; Young JW; Kleinman NL; Brook RA
    J Med Econ; 2015; 18(9):691-703. PubMed ID: 26047262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
    Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insomnia and absenteeism at work. Who pays the cost?
    Godet-Cayré V; Pelletier-Fleury N; Le Vaillant M; Dinet J; Massuel MA; Léger D
    Sleep; 2006 Feb; 29(2):179-84. PubMed ID: 16494085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who really pays for health insurance? The incidence of employer-provided health insurance with sticky nominal wages.
    Sommers BD
    Int J Health Care Finance Econ; 2005 Mar; 5(1):89-118. PubMed ID: 15714265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative valuations of work loss and productivity.
    Berger ML; Murray JF; Xu J; Pauly M
    J Occup Environ Med; 2001 Jan; 43(1):18-24. PubMed ID: 11201764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tegaserod treatment for IBS: a model of indirect costs.
    Smith DG; Barghout V; Kahler KH
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S43-50. PubMed ID: 15926763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-wage workers and health insurance coverage: can policymakers target them through their employers?
    Long SH; Marquis MS
    Inquiry; 2001; 38(3):331-7. PubMed ID: 11761361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.